{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:29:39Z","timestamp":1791358179090,"version":"4.3.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cld.2022.01.013","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:29:09Z","timestamp":1648668549000},"page":"165-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatorenal Syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Timea","family":"Csak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2022.01.013_bib1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V4101735","article-title":"Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy","volume":"4","author":"Epstein","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.cld.2022.01.013_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.013_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2014","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.cld.2022.01.013_bib4","first-page":"23","article-title":"Hepatorenal syndrome","volume":"4","author":"Gines","year":"2018","journal-title":"Nat Rev"},{"key":"10.1016\/j.cld.2022.01.013_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.01.013_bib7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0168-8278(97)80352-2","article-title":"Effect of posture-induced blood volume expansion on systemic and regional hemodynamics in patients with cirrhosis","volume":"27","author":"Iwao","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.01.013_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hep.1840160210","article-title":"The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change","volume":"16","author":"Bernardi","year":"1992","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2022.01.013_bib10","first-page":"533","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"Mechanism Dis"},{"key":"10.1016\/j.cld.2022.01.013_bib11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.01.013_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cld.2019.06.002","article-title":"Ascites and hepatorenal syndrome","volume":"23","author":"Adebayo","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.01.013_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2006.112177","article-title":"Cardiovascular complications of cirrhosis","volume":"57","author":"Moller","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cld.2022.01.013_bib14","doi-asserted-by":"crossref","first-page":"G752","DOI":"10.1152\/ajpgi.00302.2017","article-title":"Endotoxinemia-enhanced renal vascular reactivity to endothelin-1 in cirrhotic rats","volume":"315","author":"Chuang","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cld.2022.01.013_bib15","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","article-title":"The hyperdynamic circulation of chronic liver disease: from the patient to the molecule","volume":"43","author":"Iwakiri","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/jpet.106.116665","article-title":"Carbon monoxide-mediated activation of large conductance calcium-activated potassium channels contributes to mesenteric vasodilation in cirrhotic rats","volume":"321","author":"Bolognesi","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.cld.2022.01.013_bib18","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1152\/ajpgi.00467.2007","article-title":"Endocannabinoids and their receptors in the liver","volume":"294","author":"Mallat","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.013_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hep.1840180322","article-title":"Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension","volume":"18","author":"Oberti","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.01.013_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/gut.2003.024703","article-title":"Endothelin and vascular function in liver disease","volume":"53","author":"Moore","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2022.01.013_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00004836-199203000-00010","article-title":"Calcitonin gene-related peptide in hepatorenal syndrome. A possible mediator of peripheral vasodilation?","volume":"14","author":"Gupta","year":"1992","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2022.01.013_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-8278(97)80012-8","article-title":"Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins","volume":"26","author":"Battista","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.01.013_bib23","first-page":"1666","article-title":"Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation","volume":"22","author":"Laffy","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.cld.2022.01.013_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4254\/wjh.v2.i6.208","article-title":"Pathophysiology of splanchnic vasodilation in portal hypertension","volume":"2","author":"Martell","year":"2010","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cld.2022.01.013_bib26","first-page":"G1043","article-title":"NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats","volume":"276","author":"Wiest","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cld.2022.01.013_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(71)90435-1","article-title":"Renal and intrarenal blood flow in the cirrhosis of the liver","volume":"2","author":"Kew","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2022.01.013_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.1840200411","article-title":"Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index","volume":"20","author":"Maroto","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.01.013_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","article-title":"Cirrhotic cardiomyopathy","volume":"3","author":"Wong","year":"2009","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.cld.2022.01.013_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","article-title":"Cirrhotic cardiomyopathy: review of pathophysiology and treatment","volume":"8","author":"Chayanupatkul","year":"2014","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.cld.2022.01.013_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.01.013_bib33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1681\/ASN.2015010009","article-title":"Ly6C high monocytes protects against kidney damage during sepsis via a CX3CR-1-dependent adhesion mechanism","volume":"27","author":"Chousterman","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cld.2022.01.013_bib34","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"S1","key":"10.1016\/j.cld.2022.01.013_bib35","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.013_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.01.013_bib37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"1","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2022.01.013_bib39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome, relationship with kidney outcome and survival","volume":"39","author":"Sole","year":"2019","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2022.01.013_bib40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2020.11.019","article-title":"PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis","volume":"74","author":"Trebicka","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.01.013_bib41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","article-title":"Bacterial translocation (BT) in cirrhosis","volume":"41","author":"West","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.013_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and disease","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cld.2022.01.013_bib43","doi-asserted-by":"crossref","first-page":"752875","DOI":"10.3389\/fmed.2021.752875","article-title":"Acute-on-Chronic liver failure pathophysiological mechanisms and management","volume":"8","author":"Khanam","year":"2021","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.cld.2022.01.013_bib44","doi-asserted-by":"crossref","first-page":"H1016","DOI":"10.1152\/ajpheart.00779.2004","article-title":"Cytokines and vascular reactivity in resistance arteries","volume":"288","author":"Vila","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cld.2022.01.013_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2022.01.013_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jim-2019-001056","article-title":"The role of endotoxemia in causing renal dysfunction in cirrhosis","volume":"68","author":"Peng","year":"2020","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.cld.2022.01.013_bib47","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.4049\/jimmunol.168.11.5817","article-title":"Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney","volume":"168","author":"Cunningham","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2022.01.013_bib48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1681\/ASN.2007040395","article-title":"TLR4 links podocytes with the innate immune system to mediate glomerular injury","volume":"19","author":"Banas","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cld.2022.01.013_bib49","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1046\/j.1523-1755.2001.00740.x","article-title":"Endotoxemic renal failure in mice: role of tumor necrosis factor independent of inducible nitric oxide synthase","volume":"59","author":"Knotek","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.cld.2022.01.013_bib50","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 activation mediates kidney ischemia\/reperfusion injury","volume":"117","author":"Wu","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2022.01.013_bib51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.01.013_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2022.01.013_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","article-title":"Rifaximin-\u03b1 reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomized controlled trial","volume":"76","author":"Patel","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.01.013_bib54","unstructured":"Dong T, Aronsohn A, Reddy KG, Te HS. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis."},{"key":"10.1016\/j.cld.2022.01.013_bib55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/hep.24253","article-title":"Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia nd reperfusion injury","volume":"53","author":"Park","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib56","doi-asserted-by":"crossref","first-page":"G457","DOI":"10.1152\/ajpgi.00446.2016","article-title":"Deoxyribonuclease partially ameliorates thioacetamide-induced hepatorenal injury","volume":"312","author":"Vokalova","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cld.2022.01.013_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.matbio.2021.06.001","article-title":"Biglycan: a regulator of hepatorenal inflammation and autophagy","volume":"100-101","author":"Schulz","year":"2021","journal-title":"Matrix Biol"},{"key":"10.1016\/j.cld.2022.01.013_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1369\/0022155417738752","article-title":"Small leucine-rich proteoglycans in renal inflammation: two sides of the coin","volume":"66","author":"Nastase","year":"2018","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.cld.2022.01.013_bib59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000064280","article-title":"Inflammatory cytokines and lipopolysaccharide induce fas-mediated apoptosis in renal tubular cells","volume":"91","author":"Jo","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.cld.2022.01.013_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.kint.2018.10.037","article-title":"Biglycan evokes autophagy in macrophages via novel CD44\/Toll-lie receptor 4 signaling axis in ischemia-reperfusion injury","volume":"95","author":"Poluzzi","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.cld.2022.01.013_bib61","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2022.01.013_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2020.101671","article-title":"HIF-1\u03b1-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia\/reperfusion injury","volume":"36","author":"Fu","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.cld.2022.01.013_bib63","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjp.0701335","article-title":"Intrarenal haemodynamic and renal dysfunction in endotoxemia: effects of nitric oxide synthase inhibition","volume":"121","author":"Millar","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cld.2022.01.013_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"issue":"28","key":"10.1016\/j.cld.2022.01.013_bib65","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.3748\/wjg.v25.i28.3684","article-title":"Acute kidney injury spectrum in patients with chronic liver disease: where do we stand?","volume":"25","author":"Chancharoenthana","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2022.01.013_bib66","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.25573","article-title":"Adrenocortical dysfunction in liver disease: as systematic review","volume":"55","author":"Fede","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib67","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.013_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0039-1698826","article-title":"Cholemic nephropathy reloaded","volume":"40","author":"Fickert","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2022.01.013_bib69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib70","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/hep.30859","article-title":"Incidence, risk factors, and outcomes of transition of acute kidney injury to chronic kidney disease in cirrhosis: a prospective cohort study","volume":"71","author":"Maiwall","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.013_bib71","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"vanSlambrouck","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.cld.2022.01.013_bib72","first-page":"1200","article-title":"Cholemic nephropathy as cause of acute and chronic kidney disease. update on an under-diagnosed disease","volume":"11","author":"Tinti","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.cld.2022.01.013_bib73","doi-asserted-by":"crossref","first-page":"105311","DOI":"10.1016\/j.phrs.2020.105311","article-title":"The pathogenesis of renal injury in obstructive jaundice: a review of underlying mechanisms, inducible agents and therapeutic strategies","volume":"163","author":"Li","year":"2021","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.cld.2022.01.013_bib74","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/hep.30499","article-title":"Cholemic nephropathy causes acute kidney injury and is accompanied by loss of aquaporin 2 in collecting ducts","volume":"69","author":"Brasen","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2022.01.013_bib75","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/hep.26599","article-title":"Bile acids trigger cholemic nephropathy in common bile duct ligated mice","volume":"58","author":"Eckert","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.01.013_bib76","doi-asserted-by":"crossref","first-page":"718783","DOI":"10.3389\/fphys.2021.718783","article-title":"Bile acids, liver cirrhosis, and extrahepatic vascular dysfucntion","volume":"12","author":"Sauerbuch","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.cld.2022.01.013_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41100-020-00265-0","article-title":"Bile cast nephropathy: when the kidneys turn yellow","volume":"6","author":"El Chediak","year":"2020","journal-title":"Ren Replace Ther"},{"issue":"11","key":"10.1016\/j.cld.2022.01.013_bib78","first-page":"2523","article-title":"Hepatorenal syndrome: insights into the mechanisms of intra-abdominal hypertension","volume":"6","author":"Chang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cld.2022.01.013_bib79","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc6765","article-title":"Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial","volume":"12","author":"Umgelter","year":"2008","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.cld.2022.01.013_bib80","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MNH.0000000000000538","article-title":"Assessing the health of the nephron in AKI: biomarkers of kidney function and injury","volume":"28","author":"Menez","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cld.2022.01.013_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-015-9641-1","article-title":"Sepsis-induced acute kidney injury in patients with cirrhosis","volume":"10","author":"Angeli","year":"2016","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.cld.2022.01.013_bib82","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/hep.31836","article-title":"Albumin in Advanced Liver Diseases: The Good and the Bad of a Drug.","volume":"74","author":"Jagdish","year":"2021","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:58:03Z","timestamp":1761069483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1089326122000137"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.01.013","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatorenal Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}